# Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer

> **NCT00104793** · PHASE2 · COMPLETED · sponsor: **Japan Multinational Trial Organization** · enrollment: 55 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** carboplatin
- **DRUG:** irinotecan hydrochloride

## Key facts

- **NCT ID:** NCT00104793
- **Lead sponsor:** Japan Multinational Trial Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2007-02
- **Final completion:** 2008-11
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2013-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00104793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00104793, "Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00104793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*